SCHAUMBURG, Ill., Jan. 4, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that President, Chief Executive Officer and founder Jeffrey M. Yordon will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2012 at 8:00 a.m. PT.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive pharmaceutical product portfolio that fulfills the evolving needs of patients.
To learn more about Sagent, please visit www.SagentPharma.com.